Abstract:Introduction: Antifungal peptides (AFPs) have the potential to treat antifungal-resistant infections; however, their structure-function relationship remains unknown, hindering their rapid development. Therefore, it is imperative to investigate and clarify the structure-function relationships of AFPs. Objectives: This study aimed to investigate the impact of end-tagging single hydrophobic amino acids and capping the N-terminus with glycine (Gly) on the antifungal activity of peptide W4. Methods: The antifungal efficacy of the engineered peptides was initially assessed by determining the minimum inhibitory concentration (MIC) /minimal fungicidal concentration (MFC), killing kinetics, and drug resistance induction, in addition to evaluating the biocompatibility and stability. Subsequently, the antifungal mechanism was investigated using fluorescence labeling, electron microscopy, reactive oxygen species (ROS) detection, and measurement of mitochondrial membrane potential and apoptosis. The impact of the engineered peptides on Candida albicans (C. albicans) biofilm and their potential application in the scratch keratomycosis model were investigated. Results: The antifungal activity of W4 was significantly enhanced by capping Gly at the N-terminus, resulting in a decrease in average activity from 11.86 μM to 6.25 μM (GW4) and an increase in TI values by 1.9-fold (TIGW4 = 40.99). Mechanistically, GW4 exerted its antifungal effect by disrupting the cellular membrane structure in C. albicans, forming pores and subsequent leakage of intracellular contents. Concurrently, it facilitated intracellular ROS accumulation while decreasing the mitochondrial membrane potential. Additionally, GW4 demonstrated an excellent ability to inhibit and eliminate biofilms of C. albicans. Notably, GW4 demonstrated significant therapeutic potential in a C. albicans-associated keratitis model. Conclusion: Capping Gly at the N-terminus increased residue length while significantly enhancing the helical propensity of W4, thereby augmenting its antifungal activity. Our exploratory study demonstrated the potential strategies and avenues for optimizing the structure-function relationships of AFPs and developing highly effective antifungal drugs.

Histatin 5‐Inspired Short‐Chain Peptides Selectively Combating Pathogenic Fungi with Multifaceted Mechanisms

Antifungal Peptides Produced by Actinomycetes and Their Biological Activities Against Plant Diseases.

Fungus-mediated Biosynthesis of Gold Nanoparticles with Synergistic Antifungal Activity Against Multidrug-Resistant Candida Albicans

In Silico Design and Synthesis of Antifungal Peptides Guided by Quantitative Antifungal Activity

Anti-fungal peptides: an emerging category with enthralling therapeutic prospects in the treatment of candidiasis

Optimizing therapeutic efficacy of antifungal peptides via strategic terminal amino acid modification

Exploring the frontiers of therapeutic breadth of antifungal peptides: A new avenue in antifungal drugs

Hydrophobic diversification is the key to simultaneously increased antifungal activity and decreased cytotoxicity of two ab initio designed peptides

Bioinformatics Approaches Applied to the Discovery of Antifungal Peptides

Fighting pathogenic yeasts with plant defensins and anti-fungal proteins from fungi

Guanylated Hyperbranched Polylysines with High In Vitro and In Vivo Antifungal Activity

Studies on the in vitro mechanism and in vivo therapeutic effect of the antimicrobial peptide ACP5 against Trichophyton mentagrophytes

Activity and mechanism of action of antimicrobial peptide ACPs against Candida albicans

The potential of antifungal peptides derived from Lactiplantibacillus plantarum WYH for biocontrol of Aspergillus flavus contamination

Fungicidal activity of human antimicrobial peptides and their synergistic interaction with common antifungals against multidrug-resistant Candida auris

Antifungal activity of human antimicrobial peptides targeting apoptosis in Candida auris

Tetrahedral DNA nanostructure improves transport efficiency and anti-fungal effect of histatin 5 against Candida albicans

Antifungal activity of MAF-1A peptide against Candida albicans

Design of Proteolytic-Resistant Antifungal Peptides by Utilizing Minimum d-Amino Acid Ratios

Exploring the Therapeutic Potential of Scorpion-Derived Css54 Peptide Against Candida albicans

Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections